
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
The Long Run with Luke Timmerman
T Cell Therapy
The ability to redose, since I'm putting in a terminally differentiated cell, if I give you 50 million Plasma cells, you're getting 50 million plasma cells. They're not further expanding your body the way that a T cell would. And so I can navigate that, that, that dosing question with that redosing in a way that's much more like biologics than it is like a lot of the other cell therapies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.